Phytex paint

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Salicylic acid; Methyl salicylate; Tannic acid; Boric acid

Available from:

Wynlit Laboratories Ltd

ATC code:

D01AE20

INN (International Name):

Salicylic acid; Methyl salicylate; Tannic acid; Boric acid

Dosage:

8.9mg/1ml ; 5.3mg/1ml ; 48.9mg/1ml ; 31.2mg/1ml

Pharmaceutical form:

Cutaneous paint

Administration route:

Cutaneous

Class:

No Controlled Drug Status

Prescription type:

Never Valid To Prescribe As A VMP

Product summary:

BNF: 13100200

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Phytex Paint Cutaneous Solution
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Solution contains tannic acid 4.886% w/v, boric acid 3.1245 w/v,
salicylates
(as salicylic acid 0.89% w/v and methyl salicylate 0.526% v/v).
3
PHARMACEUTICAL FORM
A clear, pale straw-coloured cutaneous solution for application to
skin and
nails.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
For the treatment of infections of the skin and nails due to
superficial
dermatophytes of Candida.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
For adults, including the elderly, and children over five years:
The tincture is painted onto the affected areas morning and evening
and after
washing. Several weeks of treatment may be required to prevent
relapse.
Children under five years: Contraindicated.
4.3
CONTRAINDICATIONS
Known sensitivity to any of the ingredients. Do not use in children
under five.
Should not be used on broken or inflamed skin, Use in pregnancy.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Do not use for longer than 10 days without consulting a doctor. For
use on nail
areas and feet only. Phytex should be used with caution in patients
with
impaired circulation and diabetics. Phytex is for topical use only and
may be
harmful if taken internally.
4.5
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None stated.
4.6
FERTILITY, PREGNANCY AND LACTATION
Contraindicated
4.7
EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
Not applicable.
4.8
UNDESIRABLE EFFECTS
Slight stinging may occur on application. Any further discomfort
caused by
dryness of the skin may be due to the astringent nature of the
product.
4.9
OVERDOSE
Not applicable.
5
PHARMACOLOGICAL PROPERTIES
5.1
PHARMACODYNAMIC PROPERTIES
Borotannic complex possesses bacteriostatic and fungistatic
properties. After
application the solvent evaporates to leave a clear film over the
infected area.
Perspiration
subsequently
dissolves
the
active
complex
which
ionises
producing a low pH (about 2.0) that is